Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model
暂无分享,去创建一个
A. Remppis | W. Koch | P. Most | H. Katus | O. Müller | M. Stangassinger | P. Raake | I. Neacşu | S. Pleger | A. Jungmann | J. Ritterhoff | P. Schlegel | C. Weber | B. Krautz | S. Sauer